Back to search
Oligodendroglioma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Oligodendroglioma trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Oligodendroglioma trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This phase I/II trial tests the safety, side effects best dose and effect of retifanlimab with or without difluoromethylornithine (DFMO) for the treatment of hi…
The goal of this study is to determine the efficacy of the study drug olutasidenib to treat newly diagnosed pediatric and young adult patients with a high-grade…
This is a 3-part study. The purpose of Part 1 of the study is to evaluate the efficacy, safety, and pharmacokinetic (PK) characteristics of safusidenib in parti…
This study will enroll 6 DLT evaluable subjects (up to 12 patients total) where we will evaluate feasibility and safety of adoptive cellular therapy combined wi…
A vision-language model using preoperative MRI and clinical variables has been developed to simultaneously predict three key molecular markers in midline glioma…
This study is a clinical trial to determine the safety of inoculating G207 (an experimental virus therapy) into a recurrent or refractory cerebellar brain tumor…
The goal of this observational study is to learn whether an artificial intelligence system called GliomaAI-Oligo can help detect a specific molecular type of br…
A roll-over study to assess long-term effect in pediatric patients treated with dabrafenib and/or trametinib.